Utility of predischarge and one-month transvenous implantable defibrillator tests.
We evaluated the utility of performing predischarge implantable cardioverter-defibrillator (ICD) testing and ICD testing at 1 month in detecting ICD-related problems, identifying 4 patients with an unacceptable increase in defibrillation threshold. Given that ICD testing is noninvasive and has minimal (if any) associated risk, we recommend that predischarge and 1-month follow-up ICD testing should be performed after implantation.
Goldberger
J J
JJ
Department of Medicine, Northwestern University, Chicago, Illinois, USA.
Horvath
G
G
Inbar
S
S
Kadish
A H
AH
D000368:Aged; D017147:Defibrillators, Implantable / Q000009:adverse effects / Q000706:statistics & numerical data; D004868:Equipment Failure; D004869:Equipment Safety; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D013997:Time Factors